Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Daiichi Sankyo
Johnson and Johnson
Cantor Fitzgerald
AstraZeneca
Julphar
Mallinckrodt
Moodys
Colorcon

Generated: April 27, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,503,745

« Back to Dashboard

Which drugs does patent 6,503,745 protect, and when does it expire?

Patent 6,503,745 protects RAPIVAB and is included in one NDA.

This patent has two patent family members in two countries.
Summary for Patent: 6,503,745
Title: Cyclopentane and cyclopentene compounds and use for detecting influenza virus
Abstract:New cyclopentane and cyclopentene compounds are provided along with their use in method for detecting influenza virus.
Inventor(s): Chand; Pooran (Birmingham, AL), Babu; Yarlagadda S. (Birmingham, AL), Bantia; Shanta (Birmingham, AL)
Assignee: Biocryst Pharmaceuticals, Inc. (Birmingham, AL)
Application Number:09/831,140
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

Drugs Protected by US Patent 6,503,745

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Biocryst RAPIVAB peramivir SOLUTION;IV (INFUSION) 206426-001 Dec 19, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,503,745

PCT Information
PCT FiledNovember 05, 1999PCT Application Number:PCT/US99/26054
PCT Publication Date:May 18, 2000PCT Publication Number: WO00/28328

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Covington
Express Scripts
Moodys
McKesson
Argus Health
US Army
McKinsey
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.